/Investor DB

Oaktree — 2018 Investments

4 investments dated 2018 · listed companies and verified rows first · show all

Aquestive TherapeuticsinNASDAQ: AQSTApr 2018

Aquestive Therapeutics develops and commercializes oral film drug formulations and other novel delivery systems for treatments in neurology, psychiatry, and emergency care, operating manufacturing facilities in Indiana that produce both licensed pharmaceutical products and proprietary candidates for regulated markets including the U.S., EU, and Australia.

BiotechWarren, US

Keith J Kendall(Chief Executive Officer)inA. Mark Shobel(Chief Operating Officer)Theresa Wood(Vice President, Human Resources)inPeter Boyd(Vice President, Value Delivery)Daniel Barber(Vice President, Business and Product Development)inJohn T Maxwell(Chief Financial Officer, Treasurer, Secretary)in

Co-investorsRTW Investments L.P.

Cult.fitcure.fitin𝕏Aug 2018 · $120M

Cult.fit operates a fitness platform offering group classes, gym memberships, at-home workouts, sports facilities, nutrition coaching, and wellness services across multiple centers in India.

HealthtechWellness & FitnessBangalore, IN

Co-investorsAccelSouth Park CommonsTrifecta Capital AdvisorsChiratae VenturesGreat Oaks Venture CapitalJoyance Partners+4 more

Curegetcure.appinAug 2018 · $120M

CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.

B2B MarketplacesHealthtechSaaSBerlin, DE

Manuel Aberle(Founder)in

Co-investorsAbstract VenturesArtis VenturesFJ LabsJ12 VenturesStella CapitalAccel+23 more

Curefitcult.fitin𝕏Aug 2018 · $120M

cult.fit offers fitness memberships (cultpass) providing access to group classes, gyms, at-home workouts, and sports facilities, along with weight-loss coaching, workout gear, and wellness services.

ConsumerSports TechWellness & FitnessBangalore, IN

Mukesh Bansal(Founder)inAnkit Nagori(Founder)

Co-investorsBetter CapitalChiratae VenturesEndiya PartnersEpiq Capital Investment Advisory LLPExfinity VenturesIndia Foundation Fund Series I (A Scheme Of Multiply Ventures India+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.